This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Feb 27;319(8):829.

doi: 10.1001/jama.2017.20846.

Drug Interactions With Non-Vitamin K Oral Anticoagulants

Anne-Laure Sennesael¹, Séverine Henrard¹, Anne Spinewine²

Affiliations

Affiliations

¹ Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
² Department of Pharmacy, Centre Hospitalier Universitaire-UCL Namur, Yvoir, Belgium.

PMID: 29486029
DOI: 10.1001/jama.2017.20846

Comment

Drug Interactions With Non-Vitamin K Oral Anticoagulants

Anne-Laure Sennesael et al. JAMA. 2018.

. 2018 Feb 27;319(8):829.

doi: 10.1001/jama.2017.20846.

Authors

Anne-Laure Sennesael¹, Séverine Henrard¹, Anne Spinewine²

Affiliations

¹ Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
² Department of Pharmacy, Centre Hospitalier Universitaire-UCL Namur, Yvoir, Belgium.

PMID: 29486029
DOI: 10.1001/jama.2017.20846

No abstract available

PubMed Disclaimer

Comment in

Drug Interactions With Non-Vitamin K Oral Anticoagulants-Reply.
Chang SH, Wen MS, Kuo CF. Chang SH, et al. JAMA. 2018 Feb 27;319(8):830-831. doi: 10.1001/jama.2017.20854. JAMA. 2018. PMID: 29486031 No abstract available.

Comment on

Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH, Chou IJ, Yeh YH, Chiou MJ, Wen MS, Kuo CT, See LC, Kuo CF. Chang SH, et al. JAMA. 2017 Oct 3;318(13):1250-1259. doi: 10.1001/jama.2017.13883. JAMA. 2017. PMID: 28973247 Free PMC article.

Similar articles

Drug Interactions With Non-Vitamin K Oral Anticoagulants.
Wang N, Giblin E, Rodgers JE. Wang N, et al. JAMA. 2018 Feb 27;319(8):830. doi: 10.1001/jama.2017.20850. JAMA. 2018. PMID: 29486030 No abstract available.
Drug Interactions With Non-Vitamin K Oral Anticoagulants.
Vazquez SR, Allen A. Vazquez SR, et al. JAMA. 2018 Feb 27;319(8):829-830. doi: 10.1001/jama.2017.20842. JAMA. 2018. PMID: 29486028 No abstract available.
Drug Interactions With Non-Vitamin K Oral Anticoagulants.
Linnebur SA, Hanlon JT. Linnebur SA, et al. JAMA. 2018 Feb 27;319(8):828-829. doi: 10.1001/jama.2017.20834. JAMA. 2018. PMID: 29486026 No abstract available.
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.
Turagam MK, Velagapudi P, Flaker GC. Turagam MK, et al. Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Clin Interv Aging. 2015. PMID: 26366064 Free PMC article. Review.
Clinical Stroke prevention in atrial fibrillation.
Voukalis C, Shantsila E, Lip GY. Voukalis C, et al. J R Coll Physicians Edinb. 2017 Mar;47(1):13-23. doi: 10.4997/JRCPE.2017.105. J R Coll Physicians Edinb. 2017. PMID: 28569277 Review.

See all similar articles

Cited by

Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail.
Rohr BS, Foerster KI, Blank A, Burhenne J, Mahmoudi M, Haefeli WE, Mikus G. Rohr BS, et al. Clin Pharmacokinet. 2022 Jan;61(1):97-109. doi: 10.1007/s40262-021-01051-9. Epub 2021 Jul 17. Clin Pharmacokinet. 2022. PMID: 34273071 Free PMC article. Clinical Trial.
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.
Pham P, Schmidt S, Lesko L, Lip GYH, Brown JD. Pham P, et al. JAMA Netw Open. 2020 Apr 1;3(4):e203593. doi: 10.1001/jamanetworkopen.2020.3593. JAMA Netw Open. 2020. PMID: 32329770 Free PMC article.
Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation.
Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Xu Y, et al. J Am Heart Assoc. 2022 Jul 19;11(14):e025723. doi: 10.1161/JAHA.122.025723. Epub 2022 Jul 5. J Am Heart Assoc. 2022. PMID: 35861836 Free PMC article.
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants-a Swedish, register-based cohort study in atrial fibrillation outpatients.
Holm J, Mannheimer B, Malmström RE, Eliasson E, Lindh JD. Holm J, et al. Eur J Clin Pharmacol. 2021 Mar;77(3):409-419. doi: 10.1007/s00228-020-03015-7. Epub 2020 Oct 7. Eur J Clin Pharmacol. 2021. PMID: 33029651 Free PMC article.
Rivaroxaban Related Bilateral Adrenal Hemorrhage: A Rare Complications of Direct Oral Anticoagulants - A Case Reports.
Alidoost M, Soomro R, Gubeladze A, Morabia A, Holland S, Asif A, Hossain MA. Alidoost M, et al. Am J Case Rep. 2019 Nov 2;20:1607-1611. doi: 10.12659/AJCR.917780. Am J Case Rep. 2019. PMID: 31676747 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information